Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Príomhchruthaitheoirí: Tangui Barré (Údar), Fabrice Carrat (Údar), Clémence Ramier (Údar), Hélène Fontaine (Údar), Vincent Di Beo (Údar), Morgane Bureau (Údar), Céline Dorival (Údar), Dominique Larrey (Údar), Elisabeth Delarocque-Astagneau (Údar), Philippe Mathurin (Údar), Fabienne Marcellin (Údar), Ventzislava Petrov-Sanchez (Údar), Carole Cagnot (Údar), Patrizia Carrieri (Údar), Stanislas Pol (Údar), Camelia Protopopescu (Údar), the ANRS/AFEF Hepather study group (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: BMC, 2022-06-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...